UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

May 22, 2023

                                      

 

Ra Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-38677

 

38-3661826

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1670 Highway 160 West

Suite 205

Fort Mill, SC 29708

(Address of principal executive offices, including zip code)

 

(973) 691-2000

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

                                                   

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

RMED

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 2.02. Results of Operations and Financial Conditions.

 

The contents of Item 8.01 below are incorporated herein by reference.

 

Item 8.01.  Other Events.

 

The Company issued a press release on May 22, 2023.  A copy of that press release is attached as Exhibit 99.1 hereto and incorporated by reference herein. 

 

Item 9.01.  Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit 

 

Description

 

 

 

99.1

 

Press Release Issued on May 22, 2023

 

 

 

104

 

Cover Page Interactive Data File (formatted as inline XBRL)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

RA MEDICAL SYSTEMS, INC.

 

 

 

 

 

 

 

 

Date:  May 22, 2023

By:

/s/ Steven Passey

 

 

 

Steven Passey

 

 

 

Chief Financial Officer and Secretary

 

 

 
3

 

Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Ra Medical Systems Charts.
Ra Medical Systems (NYSE:RMED)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Ra Medical Systems Charts.